S396-0261 Screening compound: 2-[1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidin-3-yl]-N-[(pyridin-3-yl)methyl]acetamide

S396-0261 Screening compound: 2-[1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidin-3-yl]-N-[(pyridin-3-yl)methyl]acetamide
S396-0261 Screening compound: 2-[1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidin-3-yl]-N-[(pyridin-3-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S396-0261
2-[1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidin-3-yl]-N-[(pyridin-3-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S396-0261

Molecular Formula

C18H23N5O2 (C18 H23 N5 O2)

Compound Name

2-[1-(1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)piperidin-3-yl]-N-[(pyridin-3-yl)methyl]acetamide

IUPAC name

2-[1-(1-methyl-6-oxo-16-dihydropyridazin-4-yl)piperidin-3-yl]-N-[(pyridin-3-yl)methyl]acetamide

SMILES

CN1N=CC(N2CC(CC(NCc3cnccc3)=O)CCC2)=CC1=O

InChI

InChI=1S/C18H23N5O2/c1-22-18(25)9-16(12-21-22)23-7-3-5-14(13-23)8-17(24)20-11-15-4-2-6-19-10-15/h2,4,6,9-10,12,14H,3,5,7-8,11,13H2,1H3,(H,20,24)/t14-/m1/s1

InChI Key

HHUKGEZJUFCTAI-CQSZACIVSA-N

MDL Number (MFCD)

MFCD29004187

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

341.41

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

0.290

Distribution Coefficient, logD

0.034

Water Solubility, LogSw

-0.89

Polar Surface Area

66.095

Acid Dissociation Constant (pKa)

13.61

Base Dissociation Constant (pKb)

7.31

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.40

S396-0261 in Drug Discovery

Included in Screening Libraries

BRD4 Targeted Library (4534 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
Targets:
  • Others
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with S396-0261 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S396-0261?
Check Price and Availability of S396-0261, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S396-0261 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S396-0261
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S396-0261
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S396-0261 available by request